Skip to main content

Market Overview

Outlook Therapeutics, Inc. (OTLK)

2.52 -0.08 (-3.08%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2022
Pre-Market
EPS:
REV:
-0.09
0



Q1 2022
Pre-Market
EPS:
REV:
-0.12
0



Q4 2021
Pre-Market
EPS:
REV:
-0.03
0



Q3 2021
Pre-Market
EPS:
REV:
-0.11
0



Q2 2021
Pre-Market
EPS:
REV:
-0.13
0
-0.09
320K
-0.09
0
0%
-100%
Q1 2021
Pre-Market
EPS:
REV:
-0.62
0

-0.12
0

Q4 2020
Pre-Market
EPS:
REV:
-1.98
5.853M

-0.03
0

Q3 2020
Pre-Market
EPS:
REV:
-0.24
584K

-0.11
0

Q2 2020
Pre-Market
EPS:
REV:
-0.58
641K

-0.13
0

Q1 2020
Pre-Market
EPS:
REV:
-1.00

-0.62
0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!